• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

29.68 -0.18 (-0.60%)
Streaming Delayed Price Updated: 9:39 AM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,252
Open 29.72
Bid (Size) 29.52 (2)
Ask (Size) 29.82 (1)
Prev. Close 29.86
Today's Range 29.54 - 29.87
52wk Range 23.23 - 42.29
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
July 24, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
5 Hot Stocks With Summer Buybacks You Can Cash In On
July 10, 2025
The five stocks on this list issued aggressive buyback authorizations in June or July and have the power to follow through with their plans. 
Via MarketBeat

Performance

YTD
+3.7%
+3.7%
1 Month
-2.0%
-2.0%
3 Month
+9.7%
+9.7%
6 Month
-8.7%
-8.7%
1 Year
-23.0%
-23.0%

More News

Read More
1 Safe-and-Steady Stock to Keep an Eye On and 2 to Be Wary Of
July 08, 2025
Via StockStory
Collegium Announces $150 Million Share Repurchase Program
July 07, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
May 08, 2025
Via Benzinga
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
June 18, 2025
Via FinancialNewsMedia
Topics Death
1 Russell 2000 Stock on Our Watchlist and 2 to Keep Off Your Radar
June 17, 2025
Via StockStory
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
June 18, 2025
From FN Media Group LLC
Via GlobeNewswire
COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities
June 10, 2025
Via StockStory
3 of Wall Street’s Favorite Stocks with Mounting Challenges
June 10, 2025
Via StockStory
Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers
June 05, 2025
Via StockStory
Topics Artificial Intelligence Intellectual Property
1 Stock Under $50 with Exciting Potential and 2 to Turn Down
June 04, 2025
Via StockStory
Collegium to Participate in Upcoming Investor Conferences
May 19, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
3 Small-Cap Stocks Facing Headwinds
May 15, 2025
Via StockStory
Collegium Announces $25 Million Accelerated Share Repurchase Program
May 12, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 Expectations
May 08, 2025
Via StockStory
Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
May 08, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Pharmaceutical (COLL) Q1 Earnings: What To Expect
May 07, 2025
Via StockStory
3 Healthcare Stocks That Concern Us
April 28, 2025
Via StockStory
Topics Stocks
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
2 Reasons to Watch COLL and 1 to Stay Cautious
April 14, 2025
Via StockStory
What Analysts Are Saying About Collegium Pharmaceutical Stock
April 09, 2025
Via Benzinga
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack
April 02, 2025
Via StockStory
Topics Artificial Intelligence Intellectual Property
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
April 01, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
March 27, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 29.68
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 08/01/25 09:39 AM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 957.19M
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 957M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap